rwilkins on PROD1PC63 with NOTICES

Federal Register / Vol. 72, No. 191 / Wednesday, October 3, 2007 / Notices 56361 

Dated: September 26, 2007. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. E7–19531 Filed 10–2–07; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Decision To 

Evaluate a Petition To Designate a 

Class of Employees at the Y–12 

Facility, Oak Ridge, TN, To Be Included 

in the Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice as 

required by 42 CFR 83.12(e) of a 

decision to evaluate a petition to 

designate a class of employees at the Y– 

12 facility, Oak Ridge, Tennessee, to be 

included in the Special Exposure Cohort 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. The initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Y–12. 

Location: Oak Ridge, Tennessee. 

Job Titles and/or Job Duties: All 

workers. 

Period of Employment: March 1, 1943 

through December 31, 1947. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513– 

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

Dated: September 27, 2007. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. E7–19525 Filed 10–2–07; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Statement of Organization, Functions 

and Delegation of Authority 

Notice is hereby given that I have 

redelegated to the Regional Program 

Managers, Office of Child Support 

Enforcement, the following authority 

vested in me by the Assistant Secretary 

for Children and Families in the 

memorandum dated February 16, 2007. 

(a) Authority Delegated. 

1. The authority to serve as the 

Approving Official to sign audit 

determination letters only where 

resolution does not involve a cost 

disallowance. 

(b) Limitations. 

1. This redelegation shall be exercised 

under financial and administrative 

requirements applicable to all 

Administration for Children and 

Familites authorities. 

2. This authority may not be 

redelegated. 

(c) Effective Date. 

This redelegation is effective upon the 

date of signature. 

(d) Effect on Existing Delegations. 


None. 


I hereby affirm and ratify any actions 


taken by any Regional Program Manager 

which, in effect, involved the exercise of 

this authority prior to the effective date 

of this redelegation. 

Dated: August 14, 2007. 

Margot Bean, 

Deputy Director/Commissioner, Office of 

Child Support Enforcement. 

[FR Doc. 07–4885 Filed 10–2–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007N–0018] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Human Cells, Tissues, and Cellular and 

Tissue-Based Products: Establishment 

Registration and Listing; Form Food 

and Drug Administration 3356; 

Eligibility Determination for Donors; 

and Current Good Tissue Practice 

AGENCY: Food and Drug Administration, 


HHS. 


ACTION: Notice. 


SUMMARY: The Food and Drug 


Administration (FDA) is announcing 


that a collection of information entitled 

‘‘Human Cells, Tissues, and Cellular 

and Tissue-Based Products: 

Establishment Registration and Listing; 

Form FDA 3356; Eligibility 

Determination for Donors; and Current 

Good Tissue Practice’’ has been 

approved by the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of the Chief 

Information Officer (HFA–250), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–827– 

4659. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of April 27, 2007 (72 

FR 21027), the agency announced that 

the proposed information collection had 

been submitted to OMB for review and 

clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0543. The 

approval expires on August 31, 2010. A 

copy of the supporting statement for this 

information collection is available on 

the Internet at http://www.fda.gov/ 

ohrms/dockets. 

Dated: September 26, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–19454 Filed 10–2–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2006N–0475] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Human Tissue Intended for 

Transplantation 

AGENCY: Food and Drug Administration, 


HHS. 


ACTION: Notice. 


SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Human Tissue Intended for 

Transplantation’’ has been approved by 

the Office of Management and Budget 

(OMB) under the Paperwork Reduction 

Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of the Chief 

Information Officer (HFA–250), Food